Clinical Trials Browser

Phase EARLY_PHASE1 × malic acid × 90 days × Clear all

NCT07325123 2026-01-08

Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumor Malignancies